DMG PEG2000 DBCO Conjugate

<strong>DMG PEG2000 DBCO Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2013236_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> DMG-PEG2000-DBCO, DMG-PEG-DBCO, 2000 Da, DBCO PEG2000 DMG, 1,2-dimyristoyl-rac-glycero-3-polyethylene glycol 2000 DBCO_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Wei Y, Luo L, Gui T, Yu F, Yan L, Yao L, Zhong L, Yu W, Han B, Patel JM, Liu JF, Beier F, Levin LS, Nelson C, Shao Z, Han L, Mauck RL, Tsourkas A, Ahn J, Cheng Z, Qin L. Targeting cartilage EGFR pathway for osteoarthritis treatment Sci Transl Med. 2021 Jan 13;13(576):eabb3946._x000D_ 2: Qian R, Jing B, Jiang D, Gai Y, Zhu Z, Huang X, Gao Y, Lan X, An R. Multi-antitumor therapy and synchronous imaging monitoring based on exosome Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2668-2681._x000D_ 3: Wang H, Sobral MC, Zhang DKY, Cartwright AN, Li AW, Dellacherie MO, Tringides CM, Koshy ST, Wucherpfennig KW, Mooney DJ. Metabolic labeling and targeted modulation of dendritic cells Nat Mater. 2020 Nov;19(11):1244-1252._x000D_ 4: Zhang X, Goel V, Attarwala H, Sweetser MT, Clausen VA, Robbie GJ. Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure-Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis J Clin Pharmacol. 2020 Jan;60(1):37-49._x000D_ 5: Zhang C, Dai P, Vinogradov AA, Gates ZP, Pentelute BL. Site-Selective Cysteine-Cyclooctyne Conjugation Angew Chem Int Ed Engl. 2018 May 28;57(22):6459-6463._x000D_ 6: Klein PM, Wagner E. Click-Shielded and Targeted Lipopolyplexes Methods Mol Biol. 2019;2036:141-164._x000D_ 7: Lyu M, Yazdi M, Lin Y, Höhn M, Lächelt U, Wagner E. Receptor-Targeted Dual pH-Triggered Intracellular Protein Transfer ACS Biomater Sci Eng. 2022 Jul 8._x000D_ 8: Xu X, Liu L, Wang H, Li W, Zou Y, Zeng Y, Yang Q, Bai D, Dai D. Engineered DBCO+PD-1 Nanovesicles Carrying 1-MT for Cancer-Targeted Immunotherapy ACS Biomater Sci Eng. 2022 Nov 14;8(11):4819-4826._x000D_ 9: Vespa S, Del Biondo P, Simeone P, Cavallucci E, Catitti G, Auciello R, De Bellis D, Altomare I, Pierdomenico L, Canonico B, Cicalini I, Angilletta I, Del Boccio P, Pieragostino D, Santilli F, Urbani A, De Laurenzi V, Stuppia L, Lanuti P. Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions Int J Mol Sci. 2022 Nov 23;23(23):14592._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/36126444">10: Sales ZS, Mani N, Herrmann AT. Practical syntheses of DOTAGA-DBCO and DFO-DBCO, strained alkyne pre-cursors to radioimmunoconjugates for targeted alpha therapy Bioorg Med Chem. 2022 Nov 1;73:117010. </a>_x000D_ _x000D_ <strong>Products Related to DMG PEG2000 DBCO Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>